Gelesis Holdings, Inc.
GLS
Peringkat dalam Saham
#40619
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Harga Saham
$0.0121
Terakhir disinkronkan: 2023-05-23
Kapitalisasi Pasar
$97.54K
Perubahan (1 hari)
-24.38%
Perubahan (1 tahun)
12,000.00%
Negara
US
Perdagangan Gelesis Holdings, Inc. (GLS)
Kategori
Healthcare
Riwayat harga saham Gelesis Holdings, Inc. (GLS)
Harga penutupan tertinggi: $0.00 pada 2026-10-01
Harga penutupan terendah: $9.82 pada 2020-08-01
Harga penutupan terendah: $9.82 pada 2020-08-01
Riwayat harga saham Gelesis Holdings, Inc. dari 2020 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -12.13% |
| 2024 | -95.69% |
| 2023 | -99.13% |
| 2022 | -96.95% |
| 2021 | -0.60% |
| 2020 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $533.96 | 25.21% |
US
|
|
| $232.80 | 767.04% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $882.27 | 8.36% |
NL
|
|
| $290.30 | 1.99% |
BE
|
